Nissan Chemical Corporation (NNCHF) Fair Value & Analysis
Basic Materials · US · Market cap $5.3B
Analysis
Nissan Chemical Corporation (NNCHF) currently trades at $39.41, while our model-based Fair Value estimate is $39.83 — implying the stock looks roughly 1.1% undervalued today. We read business quality at 95/100 (high quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
Nissan Chemical Corporation engages in the chemicals, performance materials, agricultural chemicals, and pharmaceuticals businesses in Japan and internationally. The company provides high purity and custom chemicals; AdBlue, an urea solution; ammonia, sulfuric, and nitric acid, as well as concrete products; TEPIC, an epoxy compound; Melamine Cyanurate, a salt of melamine and iso cyanuric acid; TEPIC-VL, a liquid epoxy compound; Nissan Reishi, a health food; phenylphosphonic acid; HI-LITE, a chlorinated isocyanulate; FINEOXOCOL, a saturated fatty alcohol and acid; HARDBEADS, a spherical fine particles; STARFINE, a Triazine based adhesion; melamine polyphosphate; and NFG, a highly functional additive. It also offers performance materials comprising display, semiconductor, and inorganic materials; agricultural chemicals, such as herbicides, insecticides, fungicides, etc. for use on agricultural land, as well as in golf courses and parks; and drug substances for antiparasite drugs for a…
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.